Page 83 - Slipped Capital Femoral Epiphysis Pathogenetic and Clinical aspects

49. Fine RN (1998) Growth hormone in children with chronic renal insufficiency and end-stage renal disease. Endocrinologist 8(3):160–169
50. Brenkel IJ, Dias JJ, Davies TG, Iqbal SJ, Gregg PJ (1989) Hor-mone status in patients with slipped capital femoral epiphysis. J Bone Joint Surg Br 71(1):33–38
51. Mann DC, Weddington J, Richton S (1988) Hormonal studies in patients with slipped capital femoral epiphysis without evidence of endocrinopathy. J Pediatr Orthop 8(5):543–545
52. Nicolai RD, Grasemann H, Oberste-Berghaus C, Hövel M, Hauffa BP (1999) Serum insulin-like growth factors IGF-I and IGFBP-3 in children with slipped capital femoral epiphysis. J Pediatr Orthop B 8(2):103– 106
53. Razzano CD, Nelson C, Eversman J (1972) Growth hormone levels in slipped capital femoral epiphysis. J Bone Joint Surg Am 54(6):1224–1226
54. Papavasiliou KA, Kirkos JM, Kapetanos GA, Pournaras J (2007) Potential influence of hormones in the development of slipped capital femoral epiphysis: a preliminary study. J Pediatr Orthop B 16(1):1–5
55. Burrow SR, Alman B, Wright JG (2001) Short stature as a screening test for endocrinopathy in slipped capital femoral epiphysis. J Bone Joint Surg Br 83(2):263–268
56. Jingushi S, Hara T, Sugioka Y (1997) Deficiency of a parathyroid hormone fragment containing the
midportion and 1,25-di-hydroxyvitamin D in serum of patients with slipped capital femoral epiphysis. J 4 Pediatr Orthop 17(2):216–219
Slipped Capital Femoral Epiphysis
81